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The gastrointestinal environment in which drug products need to disintegrate before the
drug can dissolve and be absorbed has not been studied in detail due to limitations, espe-
cially invasiveness of existing techniques. Minimal in vivo data is available on undisturbed
gastrointestinal motility to improve relevance of predictive dissolution models and in silico
tools such as physiologically-based pharmacokinetic models. Recent advances in magnetic
resonance imaging methods could provide novel data and insights that can be used as a ref-
erence to validate and, if necessary, optimize these models. The conventional method for
measuring gastrointestinal motility is via a manometric technique involving intubation. Nev-
ertheless, it is feasible to measure gastrointestinal motility with magnetic resonance imag-
ing. The aim of this study was is to develop and validate a magnetic resonance imaging
method using the most recent semi-automated analysis method against concomitant per-
fused manometry method.
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Material and methods
Eighteen healthy fasted participants were recruited for this study. The participants were intu-
bated with a water-perfused manometry catheter. Subsequently, stomach motility was
assessed by cine-MRI acquired at intervals, of 3.5min sets, at coronal oblique planes
through the abdomen and by simultaneous water perfused manometry, before and after
administration of a standard bioavailability / bioequivalence 8 ounces (~240mL) drink of
water. The magnetic resonance imaging motility images were analysed using Spatio-Tem-
poral Motility analysis STMM techniques. The area under the curve of the gastric motility
contractions was calculated for each set and compared between techniques. The study visit
was then repeated one week later.
Results
Data from 15 participants was analysed. There was a good correlation between the MRI
antral motility plots area under the curve and corresponding perfused manometry motility
area under the curve (r = 0.860) during both antral contractions and quiescence.
Conclusion
Non-invasive dynamic magnetic resonance imaging of gastric antral motility coupled with
recently developed, semi-automated magnetic resonance imaging data processing tech-
niques correlated well with simultaneous, ‘gold standard’ water perfused manometry. This
will be particularly helpful for research purposes related to oral absorption where the absorp-
tion of a drug is highly depending on the underlying gastrointestinal processes such as gas-
tric emptying, gastrointestinal motility and availability of residual fluid volumes.
Clinical trial
This trial was registered at ClinicalTrials.gov as NCT03191045.
Introduction
The gastrointestinal (GI) environment in which drug products need to disintegrate prior to
dissolution and absorption of the drug has not been studied in detail due to limitations, espe-
cially invasiveness of existing techniques. Minimal in vivo data is available on undisturbed GI
motility. This information would be extremely helpful to improve the relevance of predictive
dissolution models and computational software tools that are frequently applied in preclinical
drug development to predict the systemic outcome of a drug. Classic studies of GI transit time
of pharmaceutical dosage forms as a function of GI motility showed substantial gastric vari-
ability as a function of dosage form size and (unmeasured) motility state of the stomach [1].
Large variability of gastric emptying as a function of fasted motility state (phase, I, II, III) has
been shown for fluids [2, 3] and particles [4–7]. Recent advances in magnetic resonance imag-
ing (MRI) methods could provide novel data and insights [8–11]. On-going studies using MRI
techniques have already shown that GI fluid (water) volumes can be measured [8, 11] though
the dynamic motility environment remains to be studied in more detail, particularly in an
undisturbed GI tract.
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Intraluminal pressure recording (manometry) is considered the gold standard method to
measure the contractile activity of the GI tract [12, 13]. This technique is, however, invasive
and at times poorly tolerated by patients and this may disturb motility patterns. Parts of the
bowel are inaccessible to conventional perfused manometry catheters, which are best suited to
study the more proximal and distal part of the GI tract only. Moreover, the method may have
low sensitivity to contractions that do not occlude the lumen [14–17].
Magnetic resonance imaging (MRI) provides an important potential alternative to manom-
etry with some key advantages; these include the ability to image the entire bowel, acquire
cross-sectional images, and the non-invasive nature of the technique. A number of recent pub-
lications describe MRI assessment of GI motility, including increased automation of analysis
and quantification of GI motility biomarkers [18–23]. MRI particularly could address difficul-
ties encountered with other techniques, such as collecting measurements in the presence of
food or in children and frailer patients [15].
Dynamic MRI has been used to measure the frequency and amplitude of antral contrac-
tions in previous work [19, 20]. De Zwart et al. compared the use of MRI and the barostat to
evaluate gastric motility and emptying disorders [24]. They assessed gastric accommodation to
liquid and solid meals, at rest and also after infusion of glucagon and erythromycin, which
alter gastric volume and motility respectively. The data showed that these methods signifi-
cantly correlated with each other [21, 22]. It has also been shown that MRI can assess gastric
motion and quantify the effects of metoclopramide and scopolamine on gastric motility [23].
Furthermore, the use of MRI to assess gastric motility and emptying has been validated against
gamma scintigraphy [25–28].
Over the last two decades, MRI has been used to provide quantitative detailed information
on gastric motor function. An early study compared MRI assessment of antro-duodenal motil-
ity with simultaneous water perfused manometry [29] and noted that perfused manometry
under-detected gastric contractions compared to MRI. In another study, a combination of
MRI and manometry was used to investigate antropyloroduodenal motor activity and its rela-
tion to gastric emptying [24, 30]. These results showed that manometry missed approximately
20% of the contraction waves which were detected by MRI [24]. Neither of the studies used
semi-automated analysis methods.
Recently, a new method of making semi-automated, Spatio-Temporal Motility MRI
(STMM) measurements of gastric and colonic contractions, based on changes in bowel lumen
diameter, has been introduced [31]. This has the potential to speed up data analysis and make
it less operator dependent. However, the combination of MRI and STMM analysis has not yet
been tested in vivo against simultaneous conventional manometry.
In this study, we aimed to validate automated MRI motility measures using the new STMM




The study was conducted at the Sir Peter Mansfield Imaging Centre (SPMIC) at the University
of Nottingham. The study was approved by the University of Nottingham Faculty of Medicine
and Health Sciences Research Ethics Committee (A14112016) and by the US Food and Drug
Administration Research Involving Human Participants Committee (16-073D). All partici-
pants gave written, informed consent before joining the study.
For inclusion, the participants had to be healthy and aged 18–60 years old. Health checks
included a medical history questionnaire, blood pressure and arterial pulse check. A 10 mL
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venous blood sample was taken from the forearm for a comprehensive metabolic panel (CMP)
and complete blood count (CBC) analysis. Exclusion criteria encompassed use of any medica-
tion which interferes with gastrointestinal motility, working night shifts, strenuous exercise
for> 10 h/week, known alcohol dependency, contraindications for MRI scanning as assessed
by a standard MRI safety questionnaire, pregnancy and inability to lie flat.
Eighteen healthy volunteers were recruited (9 males and 9 females). The mean age was 29
years old (with a standard deviation (SD) of 10, ranging from 19 (minimum) to 55 (maximum)
years old) and the mean body mass index was 24 ± 2 kg/m2. They took part in two identical
fasted state MRI study visits with a minimum of 1 week between visits. The study was regis-
tered with ClinicalTrials.gov with identifier NCT03191045.
Experimental design
This was a single-centre, open-label design study that consisted of two separate identical study
days up to 4 weeks apart. Participants consumed their habitual diet between each visit. Each
study visit lasted approximately 8 hours and it was divided into 5 sequential parts as shown in
Fig 1 with a focus on the fasting state periods of motility, as the fasting state is of particular
interest for oral solid drug delivery products. On arrival, the participants completed a study
day eligibility questionnaire to confirm eligibility and document adherence to overnight
fasting.
The study day began with a naso-duodenal catheter intubation which took place in a seated
position. A local anaesthetic (Xylocaine1 spray, AstraZeneca Ltd, UK) and a small amount of
water-soluble lubricant were used to ease passage through the nose (Optilube 5 g sachets, Opti-
mum Medical Solutions, Leeds UK). The naso-duodenal catheter was a custom design by Mui
Scientific (Mississauga, ON, Canada) made of clear polyvinyl chloride (PVC) plastic extrusion
tubing. It was a 16 channel, single-use, MRI compatible, water perfused catheter with an exter-
nal diameter of 12F (4.0 mm) and luminal diameter of 0.3 mm and a core of 1.0 mm with side
holes for pressure measurements placed at 5 cm intervals.
The perfused manometry system pressure to drive the water through the catheter was set at
1 bar resulting in a catheter perfusion rate of 1 mL/minute. The total length of the tube was
180 cm plus an additional 100 cm of pigtails. The tip of the tube had a small non-latex balloon
attached to allow for inflation with 5–10 mL water for MRI localization. After intubation and
resting, the participants were positioned in the MRI scanner. The latex balloon was inflated to
determine that the catheter had passed the pylorus and was positioned correctly with record-
ing ports in the stomach. The perfused manometry ports tend to record primarily antral con-
tractions whilst more proximal sensors in the wider fundal region do not record contractions
well, as such the assessment here was focused on the antral region of the stomach.
The balloon was then deflated and after a short period of adaptation, the catheter was con-
nected to the MRI compatible water-perfused manometry system (Biomedical Engineering
Fig 1. Study diagram. Schematic diagram of the study day timeline.
https://doi.org/10.1371/journal.pone.0241441.g001
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Department, The Royal Melbourne Hospital, Melbourne, Australia). The pressure was con-
verted to electrical signal just outside the scanner bore using transducers connected to the pig-
tails and secured to a MRI-compatible trolley placed next to the scanner bed. Electric cables and
pipes went through a wave guide opening and connected the transducers box to the electronics
and pressure gas cylinder placed outside the scanner room. To set reference pressure for the
catheter ports, the manometry machine was calibrated manually by gravity immediately before
and after every study session and the calibration recorded on the study session’s traces so that
malfunction or drift could be detected. An acquisition sample frequency of 25 Hz was used.
Each of the differential input lines to the pressure amplifier unit was decoupled using 470 pF
capacitors to the reference ground of the amplifier. This effectively trapped otherwise obtrusive
64 MHz RF pulses picked up from the scanner without affecting low-frequency motility infor-
mation. The pressure data was stored in a digital format data logger (Trace 1.3, Biomedical
Engineering Department, The Royal Melbourne Hospital, Melbourne, Australia). At the end of
each manometric study, the data log was extracted to be subsequently analysed using common
commercial software (MMS, Medical Measurement Systems B.V., Enschede, The Netherlands).
The second part of the study day consisted of one hour of baseline MRI measurements with
simultaneous water-perfused manometry data acquisition. MRI scanning was carried out
supine using a 1.5T General Electric HDX MRI scanner (General Electric Healthcare, Little
Chalfont, Buckinghamshire, UK). Stomach motility was assessed at intervals using a cine-MRI
acquisition set at coronal oblique planes through the abdomen, aligned to include the antral
region of the stomach. Each dynamic motility MRI scan acquired 60 sets of 4 slices over a time
window of approximately 3.5 min. Each dynamic scanning set was acquired across the abdo-
men whilst the participant breathed gently. The data were acquired using a FIESTA (True-
FISP) sequence (TR 3, TE 0.9, Flip angle 45, Slice thickness 8 mm, field of view 40 mm, matrix
size 256, and pixels 1.56 mm × 1.56 mm × 8 mm) at a repetition time for a given plane of 3.7
sec for a total duration of 224 sec.
During the third part of the study day, the participants were allowed to rest for up to an
hour outside the scanner room (during this period the manometry system was disconnected).
None of the participants wanted a long break, they took only advantage of the rest time to
stretch their legs and visit the toilet before continuing and the average time including recon-
nection was 15 min. Afterwards, they returned back to the scanner, the perfused manometry
system was reconnected and the participants drank a standard water challenge of 240 mL
while they were sitting up on the scanner bed. They were not instructed to drink the water at a
given speed, but all of the participants drank the glass of water quickly, within approximately
one minute. A drink of 240 mL of water is the current volume of water recommended by the
US Food and Drug Administration for bioavailability/bioequivalence (BA/BE) studies in the
fasted state [32, 33]. For the fourth part of the study, the participants laid in the scanner for up
to 3 hours of MRI and manometry data were collected concurrently with an optional 20 min-
utes comfort break towards the end. Throughout each part of the study, the cine-MRI acquisi-
tion blocks were interleaved with T2-weighted MRI scans carried out to visualise the state of
fluid volumes in the abdomen and also catheter positioning by inflating temporarily the tip
balloon with a small volume of fluid.
After the data collection period, the participants moved to the clinical room to remove the
tube, they were provided with refreshments and were then discharged.
Data analysis
Magnetic resonance imaging (MRI). The time series ‘cine’ data were corrected for respi-
ratory motion using Dual Registration of Abdominal Motion (DRAM) GIQuant (Motilent,
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London, UK) to provide information on the GI tract wall motion which allowed subsequent
automatic image analysis [34]. The data were then analysed using a Spatio-Temporal Motility
MRI technique (GIQuant, Motilent, London, UK) as recently described [31]. Briefly, the stom-
ach wall boundaries were first identified manually on one of the images. The boundaries were
then propagated automatically through the data set to collect wall boundary coordinates on all
images. The axis of the stomach was then drawn manually along the visible part of the lumen
as indicated by the green lines in Fig 2. Once done, the software automatically measured the
lumen diameter as a function of time at defined node points along the stomach axis as shown
by the yellow lines perpendicular to the stomach axis in Fig 2. This was performed for each
time point so that plots of the stomach diameter versus time were generated. The area under
the curve (AUC) was then calculated over the entire 3.5 min acquisition block. The output was
AUC in mm × second [34].
Fig 2. Image analysis. Example of MRI data analysis. The stomach wall boundaries and the axis of the stomach are
shown in green. The yellow lines represent the lumen diameter perpendicular to the stomach axis. AC, ascending
colon; TC, transverse colon; GB, gall bladder.
https://doi.org/10.1371/journal.pone.0241441.g002
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Water-perfused manometry. The water perfused manometry data were analysed using
commercial MMS software (Laborie, Mississauga, ON). Respiratory artefacts were removed.
The manometry traces from the gastric ports were segmented to synchronise with each 3.5
min MRI acquisition. The output was the AUC in mmHg × second [35].
Statistical analysis
The study design included power analysis considerations. Briefly, for correlation analyses
involving data that are summarized to one number per subject, the standard error for the esti-
mated correlation coefficient over 15 subjects is 0.28. However, our main analyses use time-
resolved data with an overall sample size of 421 values over the 15 subjects. Using a Kronecker
sum model to capture within-modality autocorrelation (for MRI or manometry) and between-
modality correlation (the parameter of interest), much smaller standard errors are obtained.
For example, if the within-modality autocorrelation is 0.5, the between-modality correlation
coefficient is estimated with a standard error of 0.049. Thus, the confidence intervals for the
correlation parameter of interest will be reported as the estimate +/- 0.1, giving us excellent
power to resolve weak from strong correlation. The standard error depends on the within-
modality autocorrelation, which was not known at the time of study design. The actual data
obtained showed high precision of the estimated correlation coefficient, indicating that the a
priori study design was successful.
Data were analysed using SPSS for Windows (Release 24.0, Chicago, IL) and Graph Pad
Prism 7 (GraphPad Software, San Diego, CA). All data are presented as mean ± standard devi-
ation unless otherwise indicated. A Pearson’s correlation was used to assess the agreement
between MRI area under the curve and corresponding manometry area under the curve. In
addition, mixed-effects regression was used to assess the relationship between MRI and
manometry measurements of gastric antral motility, while accounting for repeated measure-
ments within study participant and study visits. The conditional mean of the MRI 3.5 min
AUC was estimated as both a linear and nonlinear function of the manometry 3.5 min corre-
sponding AUC. There was some evidence of a nonlinear association between manometry and
MRI 3.5 min AUC measurements. A natural spline basis was used to assess whether the data
support a non-linear conditional mean structure. The mixed effects models included random
intercepts for each subject and for each visit-within-subject, and random slopes for each
participant.
Results
The study procedures were well tolerated and there were no adverse events. All the eighteen
participants returned for their second visit. Data from three participants had to be excluded
because of technical difficulties with either the MRI, the perfused manometry hardware or the
intubations, leaving 15 participants for analysis.
The MRI motility plots showed good visual correspondence compared to the perfused
manometry traces during both antral contractions and quiescence. Three examples of 3.5 min
acquisition blocks are shown in Fig 3. The two top panels show gastric contraction peaks
detected synchronously by MRI and perfused manometry, whilst the bottom panel shows a
period of quiescence sampled by both techniques. The perfused manometry traces allowed
standard quality monitoring of the antral motility in the participants as described in the mate-
rials and methods section.
Fig 4 shows the average AUC of the MRI stomach antral motility for each participant plot-
ted against the corresponding average AUC of the water perfused manometry (n = 15). As
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indicated by the Pearson’s correlation coefficient, a strong and significant correlation was
observed between both data sets (r = 0.860).
Having considered the average AUCs as above, it is also important to consider all individual
data points of the MRI motility AUCs plotted against the corresponding perfused manometry
Fig 3. MRI and manometry plots. Examples of MRI gastric antral motility plots (in red) and corresponding perfused manometry traces (in blue) from different
participants, during antral contractions (A and B) and quiescence (C).
https://doi.org/10.1371/journal.pone.0241441.g003
Fig 4. Comparison of MRI and manometry mean area under the curves. Mean (± SEM) values of manometry AUC
for each participant plotted against the corresponding mean MRI AUC (n = 15) during one of the visits (Pearson’s
correlation coefficient, r = 0.860).
https://doi.org/10.1371/journal.pone.0241441.g004
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motility AUCs across the entire study (n = 421, Fig 5). These individual points correlate
directly each individual trace without averaging noise from either measurement system. A pos-
itive, strong correlation was observed between the two techniques (r = 0.843).
The association between MRI and manometry measurements of gastric antral motility was
strong. Evidence of moderate between subject differences in MRI AUC, after controlling for
manometry AUC, was found. Controlling for manometry AUC and study subject, substantial
between-visit variation in MRI AUC was not observed. This suggests that there exist stable,
unobserved subject-level characteristics that affect MRI AUC after accounting for manometry
AUC. In addition, we also assessed whether the association between MRI and manometry
AUC measures is non-linear. The non-linear model described the observed data significantly
better compared to the linear model (w2
3
= 57.2, p< 0.001).
The association between MRI and manometry measurements was not found to vary sub-
stantially between subjects. The fitted non-linear model estimates that one standard deviation
increase in manometry AUC is associated with an MRI AUC increase of 100 mm x min for the
average subject, when manometry AUC is within one standard deviation of its mean value.
For a single subject, the model predicts that his or her expected MRI AUC increase will be
within 10 mm x min of the population average increase of 100 mm x min. The non-linear
model described the AUC data better than the linear model.
The AUC values can also be aggregated for all subjects at consecutive time points during
the study to show the time courses of gastric antral motility during the study for both MRI and
perfused manometry. These time courses are plotted together in Fig 6 to show visually the
good correspondence between the two time courses.
Discussion
The main objective of this study was to validate MRI motility measures automated using new
semi-automated MRI image analysis techniques against simultaneous water perfused manometry
in healthy adult participants. The fasting state and the use of a 240 mL dose of water as a challenge
were specifically chosen because of their relevance to the bioavailability/bioequivalence (BA/BE)
studies in the fasted state [32, 33]. However, it should be noted that the participants here did not
Fig 5. Comparison of MRI and manometry individual area under the curves. Scatter plot of individual values of
MRI antral motility for each 3.5 min imaging block AUC and the corresponding 3.5 min perfused manometry motility
AUC for all participants, thereby providing n = 421 data points (Pearson’s correlation coefficient, r = 0.843).
https://doi.org/10.1371/journal.pone.0241441.g005
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actually ingest a drug product. The recommended 240 mL of water was applied as this volume is
also used in BA/BE studies during the clinical phase of drug product development. A water drink
challenge has indeed been shown to stimulate gastric motility [36].
The study clearly demonstrated a strong correlation between the two methods. The associa-
tion between MRI AUC and manometry AUC was found to be rather non-linear than linear.
This may be due to the fact that MRI and manometry measure different features of gastric
motility. The MRI AUC is a function of the distance between the opposing stomach walls,
which cannot decrease below zero millimetres. In the case of manometry, pressure at the sur-
face of the gut reflects the force applied to a small area element on the effective mucosal sur-
face, by the fluid when the surface element is not in direct contact with other mucosal surface
elements (intrabolus hydrodynamic pressure), or when the surface element is in direct contact
with other mucosal surface elements (contact pressure) [37]. It is generally the case with peri-
staltic motility that when pressure exceeds 15–35 mmHg (referenced to mediastinal or abdom-
inal pressure as appropriate), the manometric port is generally measuring mucosal contact
pressure. Below those values, manometry generally measures hydrodynamic pressure at the
interface with intrabolus fluid [37].
Therefore, manometry AUC is a function of the pressure, which can continue to increase
while MRI measures a distance of zero mm between the gastric walls. When the stomach is
active, this will cause the manometry AUC to increase more than the MRI AUC, inducing a
non-linear relationship between the modalities. It should be noted that the non-linear model
especially improved with respect to large manometry AUC values. In the lower range,
Fig 6. Time courses of gastric antral motility. Time courses of the area under the curve of gastric antral contractile activity observed with MRI (solid
line) and water-perfused manometry (dotted line) aggregated for all subjects at consecutive intervals (mean ± SD).
https://doi.org/10.1371/journal.pone.0241441.g006
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however, a clear linear regression was observed. Conversely, Fig 6 shows a large discrepancy
between MRI and manometry AUCs with manometry being lower than MRI immediately
after the 240 mL drink. This is likely to reflect the inability of the perfused manometry to mea-
sure non-occlusive events when a free fluid is present to redistribute the pressure changes
instantaneously.
To directly quantify the details of the contractions of the gut, an imaging modality that can
resolve time changes in lumen geometry is required. Imaging and manometry are, in fact,
complementary since imaging identifies space-time changes in lumen geometry but does not
quantify muscle squeeze, while manometry directly measures muscle squeeze but not the
geometry of the lumen. Ideally, one wishes to measure both simultaneously, however, the tech-
nological challenges for concurrent measurement are sufficiently great that a single modality
data collection—pressure or imaging—is the norm. Of great interest, therefore, are the poten-
tial relationships between manometric pressure data and imaging data during contractile
activity along the gut [37] and interpretations in context with muscle function [38].
The contemporary dynamic fast acquisition of MRI has the advantage of being non-inva-
sive, safe and uses non-ionising radiation, allowing assessment of stomach contractions with
good spatiotemporal resolution [20, 39, 40]. Moreover, in comparison to manometry, the MRI
images provide superb soft-tissue contrast, which aids direct assessment of the luminal occlu-
sive and non-occlusive gastric contractions. At the same time, it allows the evaluation of the
surrounding anatomical structures. MRI can not only assist in evaluating the response to food
or a pharmacological agent but also help in a better understanding of the pathophysiology of
gastric motility disorders and drug development [21].
Whilst MRI has been repeatedly proposed as an alternative to invasive manometry, only a
few studies addressed the issue of validation of the MRI method, particularly with a view of
assessing recent automated data processing methods like STMM. Previous studies were posi-
tive but were small scale studies that acquired data for relatively short time windows [24, 29].
There is also a feasibility study on colonic motility in which dynamic MRI has been compared
to perfused manometry [39], which found a strong correlation between MRI visualized colonic
movements and intraluminal pressure changes. Advances in MRI hardware including
improved parallel imaging techniques have enabled rapid image acquisition over a large vol-
ume coverage, leading to reduced effects of motion artefacts due to respiration and peristalsis
[17]. In addition, MRI can assess the proximal and distal stomach regions simultaneously
which cannot be done by ultrasound [11, 26, 41, 42]. Also, the non-invasive characteristic of
MRI opens perspectives towards screening gastric motility in different populations (e.g. elderly
and paediatrics). Non-invasive monitoring of gastric motility has the potential to be performed
in conjunction with MRI monitoring of other physiological parameters such as evaluation of
the gastric emptying time and measurement of GI fluid volumes, which can have remarkable
effects, for instance, on orally administered drug’s residence time and dissolution, respectively
[43]. The fact that numerous physiological variables can be studied simultaneously, provides a
unique data set that can help, for instance, computer modelling of gastric function [44] and in
vitro tools to be further developed and validated. With respect to future uses of the MRI tech-
nique, a pharmacokinetic study in combination with assessment of motility could provide
unprecedented insights on inter-subject variability in systemic outcome of a drug, as the
underlying motility patterns are likely one dominant cause of known inter-subject differences
in formulation disintegration and, subsequently, dissolution and absorption of the drug. These
type of studies are the next logical step to further our understanding of to investigate the actual
assessment of pharmacokinetics variables.
Our study collected a large amount of MRI data which would have been very time consum-
ing to analyse manually with individual drawings to measure changes in the gastric luminal
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diameter over time. Much of the analysis was however done semi-automatically with the
STMM technique, which saved considerable data processing time and was less operator depen-
dent than a manual approach.
One limitation of the MRI technique is that it cannot continuously measure the motor
response of the gut over long periods of time (hours) as ambulatory manometry does. This is
not only because of cost and availability, but also because prolonged periods in the scanner
bore can be uncomfortable for patients. Therefore, the MRI methods may be more suitable to
assessing immediate impact of interventions such as meals and drugs over a relatively short
time period. The planned analysis of the motility traces was focused here on the area under the
curve of motility as primary outcomes of this study. The AUC incorporates both amplitude
and frequency of contractions in a single integral. In future more advanced analysis parame-
ters such as the Motility Index (a composite measure still incorporating both contractions fre-
quency and amplitude and also representing the fraction of time during which gastric motility
was detected) could be considered.
One may argue that the intubation of a catheter may disturb GI physiology. However, it
should be noted that the impact of transpyloric tubes on gastric emptying has been explored in
the eighties by Müller-Lissner and co-workers and no effect was observed [45]. Moreover, in
this study we allowed the participants to rest (up to 2 h) before the start of the data collection.
This gave the participant time to relax and get comfortable with the presence of the catheter.
To the extent of our knowledge, it is not known how motility may be influenced by the posi-
tion of a person (standing versus lying down). However, most of the motility studies per-
formed with manometry are those where the subject/patient is lying in a supine position. A
study performed by Treier and co-workers demonstrated differences in gastric emptying after
eating a solid/liquid meal in a lying body position or seated position [46]. However, body posi-
tion did not show any effect on gastric relaxation and initial gastric volumes. In another inter-
esting study the same group placed participants upright or upside down in an open-design
MRI scanner and concluded that the rate of gastric emptying was maintained despite the two
opposite body positions [47].
Data from MRI studies will play a pivotal role in the validation of predictive in vitro and in
silico tools as frequently used by formulation scientists in pharmaceutical drug development.
For example, MRI data from a previous study were implemented in a physiologically-based
pharmacokinetic (PBPK) simulation tool to adequately reflect the residual fluid volumes in the
different compartments of the GI tract [48, 49]. The acquired data from this study can be fur-
ther used to revise GI motility and transit times in these platforms to make predictions with
better accuracy and precision.
Conclusions
In conclusion, cine-MRI coupled with recently developed, semi-automated STMM data pro-
cessing technique is a promising method to assess gastric antral motility, which produced
results that were well correlated with simultaneous, ‘gold standard’ water perfused manometry.
Dynamic MRI is non-invasive and provides unique data on the undisturbed GI environment.
In the field of oral biopharmaceutics, the presented data are of importance to serve as a refer-
ence for validation of existing in vitro and in silico tools that are frequently applied to predict
the in vivo performance of orally administered drug products.
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